Total Payments
$19,117
2024 Payments
$504.69
Companies
20
Transactions
165
Medicare Patients
2,530
Medicare Billing
$450,638
Payment Breakdown by Category
Other$13,875 (72.6%)
Food & Beverage$4,389 (23.0%)
Travel$847.27 (4.4%)
Education$6.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,875 | 12 | 72.6% |
| Food and Beverage | $4,389 | 148 | 23.0% |
| Travel and Lodging | $847.27 | 4 | 4.4% |
| Education | $6.08 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $10,157 | 23 | $0 (2024) |
| Allergan, Inc. | $6,450 | 42 | $0 (2021) |
| Gilead Sciences, Inc. | $821.44 | 43 | $0 (2024) |
| ViiV Healthcare Company | $421.88 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $298.73 | 7 | $0 (2023) |
| Melinta Therapeutics, Inc. | $192.01 | 3 | $0 (2018) |
| Tactile Systems Technology Inc | $148.49 | 1 | $0 (2024) |
| The Medicines Company | $124.92 | 1 | $0 (2017) |
| Philips North America LLC | $97.49 | 1 | $0 (2024) |
| Stryker Corporation | $96.24 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $504.69 | 17 | Tactile Systems Technology Inc ($148.49) |
| 2023 | $446.94 | 20 | GlaxoSmithKline, LLC. ($141.52) |
| 2022 | $5,352 | 21 | ABBVIE INC. ($5,076) |
| 2021 | $5,912 | 8 | AbbVie Inc. ($4,998) |
| 2020 | $4,725 | 23 | Allergan, Inc. ($4,517) |
| 2019 | $828.35 | 21 | Allergan Inc. ($517.91) |
| 2018 | $948.29 | 38 | Allergan Inc. ($357.04) |
| 2017 | $400.49 | 17 | Allergan Inc. ($158.27) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $148.49 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/14/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 07/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 07/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 06/11/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: HIV | ||||||
| 06/06/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 05/23/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: HIV | ||||||
| 05/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Obesity | ||||||
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 04/16/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/28/2024 | Philips North America LLC | (9274) LLD (Device) | Food and Beverage | Cash or cash equivalent | $97.49 | General |
| Category: Medical Device | ||||||
| 03/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: HIV | ||||||
| 03/14/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 01/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 01/16/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: HIV | ||||||
| 12/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.61 | General |
| 12/19/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.34 | General |
| 12/14/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Vaccines | ||||||
| 12/14/2023 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.19 | General |
| 11/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Bone Health | ||||||
| 10/25/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $113.79 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.36 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 635 | 1,449 | $310,710 | $122,044 |
| 2022 | 4 | 621 | 1,298 | $273,970 | $103,594 |
| 2021 | 5 | 631 | 1,270 | $273,910 | $108,588 |
| 2020 | 5 | 643 | 1,384 | $298,750 | $116,412 |
Total Patients
2,530
Total Services
5,401
Medicare Billing
$450,638
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 322 | 1,029 | $164,640 | $70,179 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 189 | 215 | $95,675 | $31,021 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 93 | $21,390 | $9,564 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 95 | $22,800 | $8,759 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,205 | $2,521 | 40.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 347 | 943 | $150,880 | $57,062 | 37.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 180 | 190 | $84,550 | $31,997 | 37.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 86 | $19,580 | $7,450 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 79 | $18,960 | $7,085 | 37.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 325 | 896 | $143,360 | $55,896 | 39.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 179 | 195 | $86,775 | $33,761 | 38.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 70 | $16,100 | $6,544 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 62 | $14,880 | $6,506 | 43.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 31 | $10,075 | $4,460 | 44.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 16 | $2,720 | $1,421 | 52.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 330 | 927 | $148,320 | $57,968 | 39.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 201 | 220 | $97,900 | $38,594 | 39.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 53 | 150 | $34,500 | $13,561 | 39.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 72 | $17,280 | $6,110 | 35.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 11 | 15 | $750.00 | $178.22 | 23.8% |
About Sabena Ramsetty
Sabena Ramsetty is a Internal Medicine healthcare provider based in Middletown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659553394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sabena Ramsetty has received a total of $19,117 in payments from pharmaceutical and medical device companies, with $504.69 received in 2024. These payments were reported across 165 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,875).
As a Medicare-enrolled provider, Ramsetty has provided services to 2,530 Medicare beneficiaries, totaling 5,401 services with total Medicare billing of $450,638. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Middletown, NY
- Active Since 12/05/2007
- Last Updated 11/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659553394
Products in Payments
- DALVANCE (Drug) $9,169
- AVYCAZ (Drug) $4,667
- TEFLARO (Drug) $2,771
- Descovy (Drug) $229.81
- Flexitouch Plus (Device) $148.49
- AREXVY (Drug) $141.52
- SHINGRIX (Biological) $135.78
- ORBACTIV (Drug) $124.92
- RUKOBIA (Drug) $121.82
- Vabomere (Drug) $116.66
- (9274) LLD (Device) $97.49
- ANCHORAGE (Device) $96.24
- VIBATIV (Drug) $89.62
- JULUCA (Drug) $86.34
- CABENUVA (Biological) $80.92
- Baxdela (Drug) $75.35
- DOVATO (Drug) $58.67
- APRETUDE (Biological) $51.00
- Cologuard Collection Kit (Device) $50.36
- SEROSTIM (Biological) $32.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Middletown
Dr. Zainab Mogul-Ashraf, M.d, M.D
Internal Medicine — Payments: $190,519
Internal Medicine $190,519
Taraneh Soleymani, M.d, M.D
Internal Medicine — Payments: $165,396
Internal Medicine $165,396
Dr. John Ferguson, M.d, M.D
Internal Medicine — Payments: $22,796
Internal Medicine $22,796
Alexander Fruchter, Md, MD
Internal Medicine — Payments: $15,642
Internal Medicine $15,642
Dr. Angelo Paredes, M.d, M.D
Internal Medicine — Payments: $12,442
Internal Medicine $12,442
Dr. Amjad Ali
Internal Medicine — Payments: $9,482
Internal Medicine $9,482